Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

ClinicalTrials.gov ID: NCT00855855

Public ClinicalTrials.gov record NCT00855855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Surveillance for Rates of Hib Disease Among Persons 0 Through 59 Months of Age Receiving Pentacel® or Other Hib Vaccines

Study identification

NCT ID: NCT00855855
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Enrollment: 20,830 participants

Conditions and interventions

Conditions

Interventions

DTaP-IPV/Hib Biological

Biological

Eligibility (public fields only)

Age range: Up to 59 Months
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2009
Primary completion: Nov 30, 2014
Completion: Nov 30, 2014
Last update posted: Apr 24, 2022

2009 – 2014

United States locations

U.S. sites: 59
U.S. states: 10
U.S. cities: 59

Facility	City	State	ZIP	Site status
Not listed	Albany	California	94706	—
Not listed	Martinez	California	94553	—
Not listed	San Francisco	California	94102	—
Not listed	Applewood	Colorado	80401	—
Not listed	Aurora	Colorado	80011	—
Not listed	Brighton	Colorado	80601	—
Not listed	Castle Rock	Colorado	80108	—
Not listed	Denver	Colorado	80012	—
Not listed	Hartford	Connecticut	06101	—
Not listed	Adamsville	Georgia	30331	—
Not listed	Auburn	Georgia	30011	—
Not listed	Canton	Georgia	30114	—
Not listed	Carrollton	Georgia	30112	—
Not listed	Cartersville	Georgia	30120	—
Not listed	Conyers	Georgia	30012	—
Not listed	Covington	Georgia	30014	—
Not listed	Cumming	Georgia	30040	—
Not listed	Dallas	Georgia	30132	—
Not listed	Decatur	Georgia	30030	—
Not listed	Douglasville	Georgia	30134	—
Not listed	Fayetteville	Georgia	30214	—
Not listed	Good Hope	Georgia	30641	—
Not listed	Griffin	Georgia	30223	—
Not listed	Hampton	Georgia	30228	—
Not listed	Jasper	Georgia	30143	—
Not listed	Jonesboro	Georgia	30236	—
Not listed	Marietta	Georgia	30090	—
Not listed	Newnan	Georgia	30263	—
Not listed	Annapolis	Maryland	21401	—
Not listed	Saint Paul	Minnesota	55101	—
Not listed	Santa Fe	New Mexico	87501	—
Not listed	Albany	New York	12207	—
Not listed	Amsterdam	New York	12010	—
Not listed	Avon	New York	14414	—
Not listed	Batavia	New York	14020	—
Not listed	Bellona	New York	14415	—
Not listed	Canandaigua	New York	14424	—
Not listed	Catskill	New York	12414	—
Not listed	Chatham	New York	12037	—
Not listed	Geneva	New York	14456	—
Not listed	Mechanicville	New York	12118	—
Not listed	Medina	New York	14103	—
Not listed	Palmyra	New York	14522	—
Not listed	Rochester	New York	14603	—
Not listed	Schenectady	New York	12008	—
Not listed	Schoharie	New York	12157	—
Not listed	Troy	New York	12180	—
Not listed	Salem	Oregon	97301	—
Not listed	Ashland City	Tennessee	37015	—
Not listed	Charlotte	Tennessee	37036	—
Not listed	Chattanooga	Tennessee	37402	—
Not listed	Franklin	Tennessee	37064	—
Not listed	Gallatin	Tennessee	37066	—
Not listed	Knoxville	Tennessee	37902	—
Not listed	Lebanon	Tennessee	37087	—
Not listed	Memphis	Tennessee	38103	—
Not listed	Murfreesboro	Tennessee	37127	—
Not listed	Nashville	Tennessee	37201	—
Not listed	Springfield	Tennessee	37172	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00855855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 24, 2022 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00855855 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →